U. Graeven

1.5k total citations
18 papers, 661 citations indexed

About

U. Graeven is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, U. Graeven has authored 18 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in U. Graeven's work include Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuroblastoma Research and Treatments (3 papers). U. Graeven is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuroblastoma Research and Treatments (3 papers). U. Graeven collaborates with scholars based in Germany, Austria and Italy. U. Graeven's co-authors include Wolff Schmiegel, Anke Reinacher‐Schick, Rainer Porschen, Hans‐Joachim Schmoll, Stephan A. Hahn, Jütta Lüttges, Noël Bouck, Susanne Klein‐Scory, Irmgard Schwarte‐Waldhoff and Olga V. Volpert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

U. Graeven

17 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Graeven Germany 9 461 216 198 169 167 18 661
Marta Martín-Richard Spain 17 483 1.0× 238 1.1× 150 0.8× 190 1.1× 100 0.6× 42 708
Ioannis Xanthakis Greece 12 347 0.8× 161 0.7× 125 0.6× 130 0.8× 58 0.3× 30 519
C. Blajman Argentina 9 446 1.0× 425 2.0× 186 0.9× 180 1.1× 51 0.3× 15 759
Zhen-Hai Lu China 15 462 1.0× 97 0.4× 127 0.6× 182 1.1× 71 0.4× 28 614
Matthew Chau Hsien Ng Singapore 14 199 0.4× 170 0.8× 159 0.8× 132 0.8× 77 0.5× 43 455
Teruyuki SAKAGUCHI Japan 7 344 0.7× 329 1.5× 200 1.0× 197 1.2× 94 0.6× 13 651
Daitaro Yoshikawa Japan 9 398 0.9× 155 0.7× 118 0.6× 562 3.3× 151 0.9× 14 665
Marius van Rijnsoever Australia 7 329 0.7× 90 0.4× 287 1.4× 93 0.6× 308 1.8× 12 603
Maria D. Begnami Brazil 11 280 0.6× 218 1.0× 179 0.9× 157 0.9× 45 0.3× 22 560
Takashi Ichimura Japan 12 361 0.8× 274 1.3× 96 0.5× 143 0.8× 87 0.5× 52 579

Countries citing papers authored by U. Graeven

Since Specialization
Citations

This map shows the geographic impact of U. Graeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Graeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Graeven more than expected).

Fields of papers citing papers by U. Graeven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Graeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Graeven. The network helps show where U. Graeven may publish in the future.

Co-authorship network of co-authors of U. Graeven

This figure shows the co-authorship network connecting the top 25 collaborators of U. Graeven. A scholar is included among the top collaborators of U. Graeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Graeven. U. Graeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Kron, Anna, Richard Riedel, Sebastian Michels, et al.. (2017). Impact of co-occurring genomic alterations on overall survival of BRAF V600E and non-V600E mutated NSCLC patients: Results of the Network Genomic Medicine. Annals of Oncology. 28. v461–v462. 6 indexed citations
4.
5.
Pohl, Michael, Johanna Münding, Andrea Tannapfel, et al.. (2011). Biomarkers of Anti-Angiogenic Therapy in Metastatic Colorectal Cancer (mCRC): Original Data and Review of the Literature. Zeitschrift für Gastroenterologie. 49(10). 1398–1406. 26 indexed citations
6.
Schneider, C, et al.. (2010). Evaluierung der statistischen Kennwerte verschiedener kommerziell erhältlicher Stuhltests. DMW - Deutsche Medizinische Wochenschrift. 135(12). 557–562. 4 indexed citations
7.
Schmiegel, Wolff, Anke Reinacher‐Schick, Dirk Arnold, et al.. (2008). S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008. Zeitschrift für Gastroenterologie. 46(8). 799–840. 195 indexed citations
8.
Schmoll, Hans‐Joachim, Dirk Arnold, Anthony E. Lang, & U. Graeven. (2007). Nachsorge beim kolorektalen Karzinom.
9.
Schmiegel, Wolff, Gerald Adler, Wolfgang E. Fleig, et al.. (2005). S3-Guidelines Colorectal Cancer 2004. DMW - Deutsche Medizinische Wochenschrift. 130. S5–S53. 57 indexed citations
10.
Graeven, U., Steffen C. Hinz, Wolfram von Bernstorff, et al.. (2004). Phase I study of humanized IgG1 anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 plus gemcitabine (Gem) in advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 3061–3061. 4 indexed citations
11.
Graeven, U., Ida Vogel, B. Killing, et al.. (2004). Phase I study of humanized IgG1 anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 plus gemcitabine (Gem) in advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 3061–3061. 6 indexed citations
12.
Schmiegel, Wolff, Geri Adler, P. Frühmorgen, et al.. (2000). Guidelines of the DGVS. Zeitschrift für Gastroenterologie. 38(1). 49–75. 32 indexed citations
13.
Graeven, U. & Wolff Schmiegel. (2000). Das Kolonkarzinom. Der Internist. 41(9). 876–885. 3 indexed citations
14.
15.
Schwarte‐Waldhoff, Irmgard, Olga V. Volpert, Noël Bouck, et al.. (2000). DPC4/Smad4 mediated tumor suppression in pancreatic cancer cells through suppression of angiogenesis. Gastroenterology. 118(4). A50–A50. 1 indexed citations
16.
Schwarte‐Waldhoff, Irmgard, Olga V. Volpert, Noël Bouck, et al.. (2000). Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proceedings of the National Academy of Sciences. 97(17). 9624–9629. 218 indexed citations
17.
Fritscher‐Ravens, Annette, S. Petrasch, Anke Reinacher‐Schick, et al.. (1999). Diagnostic Value of Endoscopic Ultrasonography- Guided Fine-Needle Aspiration Cytology ofMediastinal Masses in Patients with Intrapulmo nary Lesions and Nondiagnostic Bronchoscopy. Respiration. 66(2). 150–155. 49 indexed citations
18.
Theegarten, Dirk, et al.. (1998). Mixed malignant germ cell tumour of the liver. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 433(1). 93–96. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Martín-Richard Breakdown of academic impact, for papers by Ioannis Xanthakis Breakdown of academic impact, for papers by C. Blajman Breakdown of academic impact, for papers by Zhen-Hai Lu Breakdown of academic impact, for papers by Matthew Chau Hsien Ng Breakdown of academic impact, for papers by Teruyuki SAKAGUCHI Breakdown of academic impact, for papers by Daitaro Yoshikawa Breakdown of academic impact, for papers by Marius van Rijnsoever Breakdown of academic impact, for papers by Maria D. Begnami Breakdown of academic impact, for papers by Takashi Ichimura
Rankless by CCL
2026